title: Increase in insulin-like growth factor I in hypertrophying smooth muscle.
abstract: The present study focuses on the role of the insulin-like growth factor (IGF) system in the development of smooth muscle hypertrophy. Hypertrophy was initiated by partial ligation of portal vein or urethra in female Sprague-Dawley rats weighing approximately 220 g. Levels of mRNA were analyzed by solution hybridization. Seven days after ligation, the wet weight of the portal vein was increased about threefold and the concentration of IGF-I mRNA was increased fourfold. The bladder wet weight was increased twofold 3 days after ligation and fourfold 10 days after ligation. IGF-I mRNA in the bladder was elevated 3-fold after 3 days and 2.5-fold after 10 days, whereas IGF binding protein 2 mRNA was increased approximately 2-fold after 3 days and 5-fold after 10 days. IGF-I receptor mRNA in the hypertrophying bladder remained unchanged. Increased levels of IGF-I were demonstrated with immunohistochemistry in both hypertrophying portal vein and urinary bladder. The results show a specific increase in IGF-I mRNA as well as an increased IGF-I immunoreactivity during hypertrophy of smooth muscle, which suggests that the local IGF-system may play a role in smooth muscle hypertrophy.
authors.affiliation: Department of Pharmacology, Faculty of Health Sciences, University of Linköping, Sweden.
authors.forename: Y
authors.initials: Y
authors.lastname: Chen
authors.forename: K E
authors.initials: KE
authors.lastname: Bornfeldt
authors.forename: A
authors.initials: A
authors.lastname: Arner
authors.forename: E
authors.initials: E
authors.lastname: Jennische
authors.forename: U
authors.initials: U
authors.lastname: Malmqvist
authors.forename: B
authors.initials: B
authors.lastname: Uvelius
authors.forename: H J
authors.initials: HJ
authors.lastname: Arnqvist
mesh_terms: D000818:Animals; D002352:Carrier Proteins / Q000235:genetics; D005260:Female; D006984:Hypertrophy; D007150:Immunohistochemistry; D018971:Insulin-Like Growth Factor Binding Protein 2; D007334:Insulin-Like Growth Factor I / Q000235:genetics / Q000378:metabolism*; D009130:Muscle, Smooth / Q000378:metabolism* / Q000473:pathology*; D009131:Muscle, Smooth, Vascular / Q000378:metabolism / Q000473:pathology; D011169:Portal Vein / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D017207:Rats, Sprague-Dawley; D017526:Receptor, IGF Type 1 / Q000235:genetics; D013002:Somatomedins; D001743:Urinary Bladder / Q000378:metabolism / Q000473:pathology
chemical_list: D002352:Carrier Proteins; D018971:Insulin-Like Growth Factor Binding Protein 2; D012333:RNA, Messenger; D013002:Somatomedins; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1